Ebola Zaire virus from the 1976 outbreak (EBO-Z) was recently adapted to the stage of lethal virulence in BALB/c mice through serial passage. In the present study, various parameters were examined in groups of mice and guinea-pigs and in three rhesus monkeys after infection with mouse-adapted EBO-Z. The virus caused fatal disease not only in mice but also in guinea-pigs, in which the course of illness resembled that produced by guinea-pig-adapted EBO-Z. Mice, guinea-pigs and monkeys showed similar haematological and biochemical disturbances, but coagulopathy was less striking in mice than in the other two species. The virus caused severe illness in all three monkeys, one of which died. In the lethally infected monkey the degree of viraemia and the haematological, serum biochemical and coagulation changes were greater than in the other two animals, an observation that may prove to be of value in predicting fatal outcome. All three monkeys developed disseminated intravascular coagulation. The two survivors were completely resistant to challenge one year later with non-adapted EBO-Z. In general, the clinical and pathological changes produced in the three species resembled those previously described in guinea-pigs and non-human primates infected with non-mouse-adapted EBO-Z. It was noteworthy, however, that mouse-adaptation appeared to have resulted in a degree of attenuation for monkeys.
Introduction
Bray et al. (1998) succeeded in producing a mouse-adapted EBO-Z, which gave rise to lethal Ebola Zaire virus (EBO-Z), a negative-sense non-infection in various mouse strains inoculated intrasegmented RNA virus belonging to the family Filo-peritoneally. A detailed study of the pathogenesis viridae, causes severe haemorrhagic fever in man of such infection in BALB/c mice was reported in (Peters et al., 1996) . Isolates from human patients the preceding paper (Gibb et al., 2001) . Within 2 cause fatal infections in non-human primates days of inoculation, the virus infected mononuclear (NHPs) (Baskerville et al., 1978; Bowen et al., 1978, phagocytic cells, including those of the spleen and 1980; Fisher-Hoch et al., 1983 , 1985 , 1992 Johnson liver, and then spread to hepatocytes, fibroblasts et al., 1995; Luchko et al., 1995; Jaax et al., 1996;  and other cell types, in a pattern similar to that in Davis et al., 1997) and non-fatal febrile illness in EBO-Z-infected GPs and NHPs (Baskerville et al., guinea-pigs (GPs) , in which a small number of 1978; Jaax et al., 1996; Peters et al., 1996 ; Davis et passages results in lethal virulence (Bowen et al., al., 1997; Connolly et al., 1999 Connolly et al., ). 1978 Connolly et al., , 1980 Connolly et al., 1999) .
Rapid viral replication results in extensive cytolysis, cytokine release, endothelial cell dys-physical interference with blood flow in the micro-EBO-Z. One subgroup of 10 mice was then held for daily observation of weight loss, illness and circulation; these changes can be recognized by clinical laboratory tests (Fisher-Hoch et al., 1983 , death, while on each day over the next five days 3-6 mice from the remainder of the cohort were 1985; Peters et al., 1996) . The purpose of the present study was two-fold: to investigate the clinical path-anaesthetized and exsanguinated, and serum or plasma was collected as described below. In two ology of mice, GPs and NHPs infected with mouseadapted EBO-Z; and to determine whether this experiments, transponder chips were implanted subcutaneously several days before inoculation, envirus would produce lethal infection in GPs and NHPs, as in mice.
abling temperatures to be measured with a handheld probe (Biomedic Data Systems, Maywood, NJ, USA). Temperatures were determined daily, Materials and Methods beginning 2 days before infection with 1 or 100 pfu.
In an initial experiment, in which mice were inViruses and Cells oculated with 1 pfu, two animals were killed each The viruses used were (1) mouse-adapted EBO-Z day and serum viral titres were determined. (Bray et al., 1998; Gibb et al., 2001) , (2) "GPadapted virus", EBO-Z '76 passaged twice in Vero Guinea-pigs. Adult strain-13 GPs were obtained cells and four times in GPs, and (3) EBO-Z '95, from the USAMRIID breeding colony and strainisolated from the 1995 Zaire outbreak and passaged 2 GPs from the NCI. Experiments were performed three times in Vero cells. The latter two viruses as described above for mice, but with 3-6 animals were provided by Dr Peter Jahrling, USAMRIID. in every subgroup. GPs were infected with mouseVero 76 monkey kidney cells (ATCC CRL 1587) adapted or GP-adapted EBO-Z by injecting 0·1 ml and the E6 clone of Vero cells (Vero C1008, ATCC of viral suspension intraperitoneally or sub-CRL 1586) were used for viral amplification and cutaneously. The LD 50 of each virus was estimated titration of samples. Cells were propagated in by infecting groups of four animals intraEagle's minimal essential medium with Earle's salts peritoneally or subcutaneously with serial 10-fold (EMEM), non-essential amino acids, fetal bovine dilutions of virus and observing them for illness and serum (FBS) 10%, glutamine, penicillin, and strep-death. In one study, strain-2 guinea-pigs received tomycin at 37°C in a 5% CO 2 atmosphere. Viral implanted transponder chips and temperatures titres were determined as described by Bray et al. were monitored, beginning 2 days before infection. (1998). The 50%-plaque-reduction neutralization Blood was collected either by venipuncture under titre (PRNT 50 ) of serum samples was determined by anaesthesia or by terminal exsanguination. heating the samples at 56°C for 30 min, incubating serial two-fold dilutions with a fixed quantity of Monkeys. Three 8-kg rhesus monkeys (Macaca mu-EBO-Z '95 virus for 30 min at 37°C, and identifying latta), nos 8709, K439 and H873, were inoculated the dilution of serum that caused a 50% reduction intramuscularly with 5000 pfu of mouse-adapted in the number of plaques, as compared with normal virus. The animals were then observed daily and serum.
examined and bled under anaesthesia from the femoral vein at intervals of 2-3 days. Two animals (K439 and H873) survived infection and remained EBO-Z Infection of Animals in BSL-4 accommodation, where blood samples Infectious material and animals were handled in were collected every 2 months. Thirteen months maximum-containment biological safety level 4 after infection, both monkeys together with four (BSL-4) facilities at the USAMRIID. Laboratory Macaca fascicularis monkeys (three members of an personnel wore positive-pressure protective suits experimental vaccine group and one untreated equipped with high-efficiency particulate air filters control) were challenged by intramuscular inand supplied with "umbilical-fed" air. All ex-oculation with 5000 pfu of EBO-Z '95. They were periments were conducted in accordance with again observed daily and bled under anaesthesia animal welfare guidelines (Gibb et al., 2001) .
at intervals of 2-3 days.
Mice. 1000 pfu only slightly shortened the mean time to onset of illness and death. Virus could not be detected in the serum on day 1 after any dose, but was present on day 2 and rose rapidly thereafter (Fig. 1A) . By day 4, serum viral titres were in the 1 pfu (30 LD 50 ) or 100 pfu, or were left uninfected, no temperature elevation was observed (Fig. 1A) . range of 10 8 -10 9 pfu/ml, regardless of the size of the inoculum. In two experiments in which body Body temperatures fell as the mice became moribund. temperatures were monitored in mice infected with GPs. Unexpectedly, the highest titres occurred in GPs receiving mouse-adapted, rather than GPadapted virus (Fig. 2B ). Body temperatures began to rise above baseline on day 5-6, coinciding with an increase in serum viral titres to values of >10 3 pfu/ml (Fig. 1B) . The animals remained febrile for 2-3 days, viral titres increasing to 10 7 pfu/ ml, after which temperatures fell as death approached.
Monkeys. The mean body temperature of the three monkeys inoculated with mouse-adapted EBO-Z rose from 38·9°C on day 2 to 40·2°C on day 5 post-infection, and remained above 40°C up to day 12 (Fig. 1C) . (Through an oversight, temperatures were not measured on day 0.) All three animals showed a reduction in activity and food intake on day 5. Monkey 8709 became markedly depressed over the next 2 days. By day 7 it had developed a fine reddish-purple maculopapular rash over the trunk and in the axillae. Conjunctival haemorrhages were present, but no frank bleeding was observed. Serum viral titres were 1·2×10 7 pfu/ml on day 5, and 4×10 7 pfu/ml on day 7 (Fig. 1C ). The animal was found dead on the morning of 6×10 4 on day 7) (Fig. 1C ). Both were free of viraemia on day 9, but remained febrile up to day 12. They became afebrile and were fully active by day 14. The PRNT 50 of both monkeys against Guinea-pigs. Mouse-adapted EBO-Z caused lethal EBO-Z '95 were 80 and 40 at 2 and 13 months illness with uniform signs in strain-2 and strain-13 after infection, respectively. Both remained healthy GPs. By contrast, GP-adapted EBO-Z did not cause after challenge with EBO-Z '95 at 13 months, illness in adult mice (not shown). In both GP strains, without detectable viraemia or changes in laboratthe LD 50 of mouse-adapted and GP-adapted EBO-ory parameters (see below). Four M. fascicularis Z was <1 pfu intraperitoneally and 10 3 -10 4 pfu monkeys challenged at the same time became ill subcutaneously (in contrast to mice, in which sub-and died on day 6 or 7 post-infection. cutaneous inoculation of >10 6 pfu of mouse-adapted virus did not cause disease).
Mouse-adapted and GP-adapted EBO-Z caused Haematology almost identical illnesses after intraperitoneal inoculation, with onset of weight loss on day 4-5, Haemoglobin and haematocrit (hg and hct). In mice, both hg and hct increased over the course of and death at 8-9 days post-infection ( Fig. 2A) . Subcutaneous inoculation resulted in a later onset infection (Fig. 3) . In the example shown (100 pfu inoculum) the hg increased from a mean of 15·5 g/ of illness. Viraemia appeared later in GPs than in mice (on day 5-6 after intraperitoneal inoculation dl on day 0 to values of 16·1-16·7 on days 4 and 5, and the hct rose from 43% on day 0 to 50% on with 100 pfu of mouse-adapted virus), and increased more slowly (Fig. 1B) . Serum viral con-day 4 and 51% on day 5. Similar increases in hg and hct were measured in GPs lethally infected centrations on day 7 post-infection were higher in intraperitoneally than subcutaneously inoculated with mouse-adapted EBO-Z (not shown). By contrast, two different patterns of change in hg and hct were observed in the monkeys (Fig. 3) . The two animals whose infection was not fatal the day before death. These changes were consistent with haemoconcentration due to dehydration and fluid shifts.
White blood cells (WBCs). EBO-Z-infected mice
showed a marked rise in total WBC count, with an but its total WBC count on that day did not differ increase in the percentage of polymorphonuclear from those of the other two animals. leucocytes (PMNs). In the 100 pfu challenge experiment cited above, total WBC counts (cells/ mm 3 ) were 2000-5000 on days 0 and 1, Platelets. Mice showed a decline in platelet counts over the course of illness (Fig. 5A ). In the 100-4000-12 000 on day 3 and 5000-20 000 on day 5 (Fig. 4A) . This resulted from an increase in PMNs, pfu infection experiment, the platelet count had dropped 55% by day 4, while a decline of 67% accompanied by a decline in the total lymphocyte count (Fig. 4A) .
from baseline was observed by day 5 in a second experiment. Strain-2 GPs infected with mouseAll three monkeys developed a leucocytosis by day 5, with WBC counts (cells/mm 3 ) of from 6000-adapted EBO-Z also showed a profound drop in platelet count, similar to that previously observed 8000 on day 0 and 10 000-16 000 on day 5 (Fig.  4B ). This was accompanied by an increase in per-in strain-13 GPs infected with GP-adapted EBO-Z (Connolly et al., 1999) . In monkeys, the lethally centage of PMNs, from 23-47% on day 0 to 63-79% on day 5. The rapid rise was followed by a infected animal showed the most rapid and profound decline in platelet count, namely a 76% drop precipitous fall in WBC count on day 7, with a shift to lymphocytosis, and a return to high circulating by day 7 (Fig. 5B) . The platelet counts of the other two monkeys declined more slowly, to 50-69% by counts (Fig. 4B) . The lethally infected monkey had the highest percentage of PMNs on day 5 (79%), day 9, before starting to recover. had increased from c. 14 to >25 s, and the latter from 30 to 70 s, by day 8 (Fig. 6B) . Plasma fibrinogen concentration showed no change from baseline values.
Monkeys. All three animals developed significant coagulation abnormalities, which were most striking in the lethally infected monkey. This animal showed a marked prolongation of aPTT and TT and a lesser change in PT, which increased up to day 7 (Fig. 6C) . The two survivors displayed similar prolongation of the aPTT, but it was slower in onset, peaking at day 9 and returning gradually to normal. The plasma fibrinogen concentration in the lethally infected monkey decreased from the baseline value, but in the other two animals it increased and remained elevated up to day 14 (Fig.  7A) .
FDPs and D-dimers, detected in the plasma of all three monkeys, were consistent with disseminated intravascular coagulation (DIC) (Fig. 7B,C) . The lethally infected monkey was distinguished by a rapid rise in both parameters; it was the only one positive for FDPs on day 5. FDPs and D-dimers rose more slowly in the other two monkeys but remained positive in both up to day 14. (Blood samples were not collected beyond that point.)
Serum Biochemistry
Mice. EBO-Z-infected mice resembled NHPs in having marked elevations of the liver enzymes AST and ALT in the serum. In the 100-pfu infection experiment, the AST became elevated on day 3 and was 20-fold above the baseline value on day 5 (Fig. 8A) . The ALT increased approximately 10-fold (not shown). The AP and GGT were also mildly elevated by day 5, and there was a slight increase in total bilirubin (Fig. 8A) . The BUN in AP, LDH and total bilirubin were also noted. By contrast, the AST and ALT of the two survivors were only 2-3 times the baseline values on day 7. infected rhesus monkey. In mice, the onset of visible In the lethally infected monkey, the BUN values illness and weight loss was associated with a rapid were 14 and 58 U/ml on days 0 and 7, respectively. rise in viraemia on day 3 post-infection, but no The corresponding Cr values were 0·9 on day 0 temperature elevation was observed. It is known and 3·5 on day 7 (Fig. 8C) . These parameters that a number of infectious agents do not induce barely changed in the other two animals. a febrile response in mice. In fact, several investigators have shown that artificial elevation of body temperature increases the resistance of mice Discussion to severe infection, at least in part by "up-regulating" the release of cytokines (Arif et al., 1999 ; The course of illness in EBO-Z-infected mice differed slightly from that in GPs and the lethally Jiang et al., 1999 Jiang et al., , 2000 . It is thus possible that the Mouse-adapted EBO-Z caused similar changes in hg, hct, WBC count and platelet count in all three animal species. The hg and hct increased over the course of illness in all lethally infected animals, consistent with haemoconcentration due to dehydration or fluid shifts. Such changes were previously observed in GPs infected with GP-adapted EBO-Z (Connolly et al., 1999) . Neither hg nor hct increased in the two monkeys that survived infection, indicating that the increase in these parameters was associated with the development of shock. Mice showed a rise in WBC count and in percentage of PMNs, similar to that previously observed in GPs (Connolly et al., 1999) . All three monkeys, on the other hand, showed a rise and fall in total WBCs, with an early increase in percentage of PMNs. The same pattern was previously observed in NHPs and in a human case of Ebola Cô te d'Ivoire (EBO-CI) infection (Fisher-Hoch et al., 1983 ,1985 Formenty et al., 1999) . The lethally infected monkey could not be distinguished from the other two on the basis of the total WBC count, but it had the highest percentage of PMNs. Mouseadapted virus caused a marked decline in platelet counts in all three animal species. This began earlier in the fatally infected monkey than in the two surviving animals.
Initial observations of lethally infected mice revealed the occasional occurrence of gross haemorrhage and the failure of blood samples to clot, suggesting the presence of a coagulation defect (Bray et al., 1998) . However, in contrast to findings in guinea-pigs and monkeys, pathological studies failed to reveal significant amounts of fibrin in the in the plasma of GPs and mice. All three monkeys showed typical features of DIC, which have previously been detected in EBO-Z-infected NHPs and in human patients infected absence of a febrile response in the presence of lethal infection results from a suppressive effect with EBO-CI and Marburg virus. These features included decreased platelet counts, prolongation of of the invading pathogen on the innate immune response. The progression of illness was slower in PT and aPTT, circulating FDPs, decreased plasma fibrinogen and extensive fibrin deposition in tissues GPs than in mice or monkeys. Thus, after infection with 100 pfu, viraemia was not detected until day (Fisher-Hoch et al., 1983 , 1985 Gear, 1989; FisherHoch and McCormick, 1998; Ryabchikova et al., 4 , weight loss began on day 4-5, body temperatures did not begin to rise until day 6, and the peak Formenty et al., 1999) . The consumptive coagulopathy is generally assumed to be serum viral titre was not reached until day 8. caused by extensive virus-induced tissue injury and fluid shifts, shock and death. These severe disruptions explain many of the abnormalities seen in the dysfunction or damage of platelets and endoclinical laboratory tests: haemoconcentration, with thelial cells (Fisher-Hoch et al., 1983 , 1985 . As a rise in hg and hct; mobilization of granulocytes; noted by other investigators, the increase in the consumption of platelets; disturbance of coaPTT was more marked than that of the PT, agulation pathways; and release of enzymes from consistent with a greater disturbance of the intrinsic infected hepatocytes. The principal difference bethan the extrinsic coagulation pathway (Fishertween the terminal stages of illness observed in Hoch et al., 1983) . Interestingly, maximal levels of mice and monkeys, as discussed above, relates to FDPs and D-dimers were similar in the lethally the apparent paucity of features of coagulopathy and non-lethally infected animals, although they in the former, in contrast to the classic madeveloped earlier in the former. The monkey that nifestations of DIC observed in the latter. We died was the only one to show a decrease in cannot currently determine whether DIC does or fibrinogen, consistent with a more severe degree does not occur in mice, because of the lack of of consumptive coagulopathy. This may reflect reagents for measuring FDPs and D-dimers. severe liver involvement, as indicated by the high Mouse-adapted EBO-Z is the only EBO virus serum AST concentration, rendering the animal that causes lethal illness in mice and GPs and unable to synthesize fibrinogen at a rate sufficient severe disease in non-human primates. Human to maintain a normal serum level. The increased EBO-Z isolates do not cause disease on injection fibrinogen levels in the other two monkeys probably into adult immunocompetent mice and cause only represented part of an acute phase reaction.
mild illness in GPs ( Van der Groen et al., 1979 ; Elevations in serum concentrations of the liver- Bowen et al., 1980) . GP-adapted EBO-Z also does associated enzymes AST and ALT were similar in not cause disease in mice, but is fully lethal for mice and in the lethally infected monkey. They monkeys (Bowen et al., 1978; Fisher-Hoch et al., resembled those previously reported for lethally 1985; Bray, unpublished data). Various pieces of infected GPs and NHPs and for human cases of evidence suggest that mouse-adapted EBO-Z was EBO CI and Marburg infection (Gear et al., 1975 ; selected over the course of serial passage in mice Fisher-Hoch et al., 1985; Connolly et al., 1999;  for its ability to subvert or evade innate antiviral Formenty et al., 1999; Ryabchikova et al., 1999) . resistance mediated by the type I interferon (IFNThis finding was not unexpected, since the hepatic / ) response, enabling it to overwhelm its host lesions in EBO-Z-infected mice, guinea-pigs, mon- (Bray, 2001) . A single mutation appears to permit keys and human patients are virtually identical the virus to suppress the type I IFN response in GPs, (Bray et al., 1998; Ryabchikova et al., 1998 ; Zaki but makes it more susceptible to innate antiviral and Goldsmith, 1998; Connolly et al., 1999 ; Gibb mechanisms of monkeys, causing it to be partially et al., 2001) . Interestingly, mice differed from GPs attenuated. A back-mutation at this site may have and the lethally infected monkey in displaying a been responsible for the lethal illness in monkey decrease in BUN, rather than an increase, over the 8709. course of illness, perhaps reflecting a severe degree This conclusion, although based on the survival of hepatic injury and a consequent decline in urea of only two of three animals, may be significant if synthesis.
"historical" controls are included in the conAs shown in this study and the accompanying siderations. Studies cited above, performed over paper by Gibb et al. (2001) , lethal infection with more than 20 years, have demonstrated that EBOmouse-adapted EBO-Z in normal adult BALB/c Z is lethal for rhesus and cynomolgus macaques, mice has many points in common with the lethal African green monkeys and baboons. Of more than disease caused by non-adapted EBO-Z in primates. 60 animals described in published reports, only Of greatest importance are the virus's predilection one survived infection (Fisher-Hoch et al., 1983) . for cells of monocyte/macrophage lineage, its rapid (By contrast, EBO Sudan and EBO Reston do not rate of replication together with the lytic nature of cause uniform mortality in NHPs [Fisher-Hoch et infection, and the ability of the virus to infect other al., 1992].) If infection of monkeys with mousecell types. This combination of factors leads, within adapted EBO-Z consistently results in the survival days of initial exposure, to infection of mobile and of a significant percentage of animals, such a model fixed tissue macrophages throughout the body, and may prove useful for studying the role of host to spread of the virus to hepatocytes, fibroblasts, responses in determining the outcome of EBO-Z adrenal cortical and other cells, with massive cy-infection. It is worth noting that the two surviving monkeys represent the first NHPs in which solid tolysis, coagulopathy, endothelial cell dysfunction, and Simpson, D. I. (1980 would be of great interest for defining the humoral Bowen, E. T. W., Platt, G. S., Simpson, D. I. H., and cell-mediated basis of immunity to EBO-Z
